Cellectis S.A. SEC filings CLLS

Cellectis S.A. has 534 filings in SEC EDGAR's recent list, going back to Dec 19, 2014. Its latest annual report, Form 20-F, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
20-F Annual report (foreign issuer) Mar 20, 2026 Dec 31, 2025
20-F/A Amended annual report (foreign issuer) Mar 14, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Mar 14, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Apr 29, 2024 Dec 31, 2023
20-F/A Amended annual report (foreign issuer) Oct 31, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 14, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 3, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 4, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Mar 5, 2020 Dec 31, 2019
20-F/A Amended annual report (foreign issuer) Apr 25, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 12, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 13, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Mar 23, 2017 Dec 31, 2016
20-F Annual report (foreign issuer) Mar 21, 2016 Dec 31, 2015

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CLLS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
France
Headquarters
Paris, Lle-De-France
SEC filer status
Accelerated filer
SEC CIK
1627281

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.